News
Industrial fermentation using bacteria, yeast and other microbes to produce specific products has the potential to reduce ...
Researchers used gene-editing technique CRISPR to modify the DNA sequences of house spiders, causing them to produce red ...
Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...
Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...
Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...
Medable has launched a digital-first Long-Term Follow-Up (LTFU) model intended for cell and gene therapy (CGT) trials.
The edited sheep contains no foreign DNA, distinguishing it from transgenic organisms and paving the way for regulatory ...
After first gene edited Pashmina Goat, Noori was born, the scientists at SKUAST helped deliver a cloned gene-edited sheep in Kashmir ...
Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...
BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...
Max Lian gets you up to date with some of the latest scientific news, including gene editing and electricity-storing cement ...
Market Value and Growth In 2025, the Gene Therapy For Rare Disease Market Size is valued at approximately US$ 3.01 Billion in 2024, marking a substantial increase from previous years. This growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results